Dennis Zhu, MD
Cardiovascular Disease · Saint Paul, MNNPI 1558338699
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $8,530 of the $12,276 with a category attached, or 69.5%. 3 manufacturers reported payments, led by Biotronik Inc. at 55.5% of the total. 2025 is the largest year on record at $5,005, 3.0 times the $1,662 reported in 2019.
Across 82 payments — averaging $149.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotronik Inc.$7K
- Medtronic$5K
- Atricure, Inc.$17
What the payments were for
- Travel & lodging$8,53069%
- Food & beverage$3,74531%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotronik Inc. | 42 | $6,817 |
| Medtronic(2 entities) | 39 | $5,441 |
| Atricure, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,276 in reported general payments places this provider in the 75th percentile of 451 cardiovascular disease providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 164 | $204,059 |
| XareltoRivaroxaban | 44 | $61,356 |
| MultaqDronedarone Hcl | 11 | $16,590 |
| Flecainide Acetate | 160 | $6,378 |
| SotalolSotalol Hcl | 168 | $3,863 |
| Metoprolol Succinate | 141 | $2,269 |
| Amiodarone Hcl | 100 | $2,013 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 47 | $1,447 |
| Carvedilol | 13 | $195 |
| Metoprolol Tartrate | 15 | $149 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Saint Paul
- Thomas BiggsSaint Paul$244K
- Pierce VatterottSaint Paul$146K
- Spencer KuboSaint Paul$134K
- Johannes BrechtkenSaint Paul$100K
- Nishtha SodhiSaint Paul$50K
- Jeffrey ChambersMinneapolis$3.2M
- Srijoy MahapatraRochester$1.2M
- Markus MeyerMinneapolis$786K
- Robert SchwartzMinneapolis$502K
- Robert VantasselMinneapolis$493K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.